Information Journal Paper
APA:
Copy. (2020). Novel thiosemicarbazones induce high toxicity in estrogen-receptor-positive breast cancer cells (MCF7) and exacerbate cisplatin effectiveness in triple-negative breast (MDA-MB231) and lung adenocarcinoma (A549) cells. INVESTIGATIONAL NEW DRUGS, 38(3), 558-573. SID. https://sid.ir/paper/749287/en
Vancouver:
Copy. Novel thiosemicarbazones induce high toxicity in estrogen-receptor-positive breast cancer cells (MCF7) and exacerbate cisplatin effectiveness in triple-negative breast (MDA-MB231) and lung adenocarcinoma (A549) cells. INVESTIGATIONAL NEW DRUGS[Internet]. 2020;38(3):558-573. Available from: https://sid.ir/paper/749287/en
IEEE:
Copy, “Novel thiosemicarbazones induce high toxicity in estrogen-receptor-positive breast cancer cells (MCF7) and exacerbate cisplatin effectiveness in triple-negative breast (MDA-MB231) and lung adenocarcinoma (A549) cells,” INVESTIGATIONAL NEW DRUGS, vol. 38, no. 3, pp. 558–573, 2020, [Online]. Available: https://sid.ir/paper/749287/en